Abstract
Multiplex ligation‐dependent probe amplification (MLPA) is a new assay for the detection of multiple chromosomal deletions in tumor tissue in a single experiment. Since genotyping of gliomas with oligodendroglial features by the detection of 1p/19q chromosomal deletions became essential for treatment decisions, we developed and validated an MLPA‐ based assay to determine these losses in formalin fixed and paraffin embedded oligodendroglial tumors (OG). Nineteen OGs, and 10 control samples were analyzed by MLPA and the results were correlated with those obtained by fluorescent in situ hybridization (FISH). The MLPA results were reproducible in all samples in which repeated experiments were performed. In 18 of 19 OGs, MLPA and FISH were concordant for presence or absence of 1p deletion. In 3 OGs, MLPA detected a 19q deletion not shown by FISH. For the other 15 OGs, MLPA and FISH were concordant. In one sample with 50% to 75% of tumor, MLPA failed to detect the 1p/19q deletions revealed by FISH (though with borderline values of significance). We conclude that MLPA is a valid and reproducible method for the detection of 1p/19q chromosomal deletions in OGs stored on formalin fixed, paraffin embedded tissue.
Full Text
The Full Text of this article is available as a PDF (262.7 KB).
References
- 1. Bigner SH, Matthews MR, Rasheed BKA, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155:375–386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C, Wainman N, Eisenhauer E (1994) Chemotherapy for Anaplastic Oligodendroglioma. J Clin Oncol 12:2013–2021. [DOI] [PubMed] [Google Scholar]
- 3. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Instit 90:1473–1479. [DOI] [PubMed] [Google Scholar]
- 4. Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892–897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hatanpaa KJ, Burger PC, Eshleman JR, Murphy KM, Berg KD (2003) Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest 83:419–428. [DOI] [PubMed] [Google Scholar]
- 6. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K (2001) Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real‐time quantitative polymerase chain reaction assay. Am J Pathol 158:1253–1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Postma C, Hermsen M, Coffa J, Baak J, Mueller J, Mueller E, Bethke B, Schouten J, Stolte M, Meijer G (2005) Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 205:514–521. [DOI] [PubMed] [Google Scholar]
- 8. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular‐genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19Q and 1P. Am J Pathol 145:1175–1190. [PMC free article] [PubMed] [Google Scholar]
- 9. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation‐dependent probe amplification. Nucl Acids Res 30:e57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB (1999) Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18:4144–4152. [DOI] [PubMed] [Google Scholar]
- 11. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645. [DOI] [PubMed] [Google Scholar]
- 12. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF (1993) Detection of Ip36 Deletions in paraffin sections of neuroblastoma tissues. Genes Chrom Cancer 6:1–9. [DOI] [PubMed] [Google Scholar]
- 13. Van Den Bent MJ, Looijenga LHJ, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Smitt PAS, Jenkins RB, Kros JM (2003) Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 97:1276–1284. [DOI] [PubMed] [Google Scholar]
- 14. Worsham MJ, Pals G, Schouten JP, van Spaendonk RM, Concus A, Carey TE, Benninger MS (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:702–708. [DOI] [PubMed] [Google Scholar]